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 Large lifestyle interventions have been effective in preventing type 2 diabetes 
(T2D) in high-risk individuals. However, the effects of translational studies at the 
community level are less consistent. The purpose of this study was to determine the 
efficacy of the National Diabetes Prevention Program (NDPP) to reduce the risk for T2D 
via improvements in body weight, body composition, glucose management, and quality of 
life (QOL) in members of the University of Utah community who are at elevated risk for 
developing T2D. Forty-seven prediabetic University staff and faculty were enrolled in a 
year-long group-based translation of the NDPP. The intervention employed two goals: 
achieving > 7% weight loss, and obtaining > 150 minutes/week of moderate intensity 
physical activity. After the 12-month intervention, improvements were observed in body 
weight (-4.82%, p < 0.001), BMI (-5.20%, p < 0.001), waist circumference (-4.56%, p < 
0.001), hip circumference (-4.50%, p < 0.001), systolic blood pressure (-5.94%, p < 0.001), 
6-minute walk distance (7.15%, p = 0.001), oral glucose tolerance (-8.41%, p < 0.028), and 
QOL scale (8.3%, p < 0.001). There were no significant effects (p > 0.05) on waist-to-hip 
ratio, diastolic blood pressure, or fasting blood glucose. A small but significant increase in 
HbA1c was detected. At study completion, only 28% of participants had achieved the 
weight loss goal, but 52% of participants had achieved the physical activity goal. There 
was a significant positive correlation between the number of goals met and improvements 
in body weight (rS = 0.61, p < 0.001), BMI (rS = 0.56, p < 0.001), waist circumference (rS 
iv 
= 0.39, p = 0.007), and hip circumference (rS = 0.33, p = 0.024), but no association between 
goals met and change in glucose management variables. Despite limited effect on markers 
of glucose management, these results confirm the feasibility of the NDPP’s lifestyle 
intervention to improve risk factors associated with T2D in members of the University of 
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Type-2 diabetes (T2D), which is characterized by progressive insulin resistance 
and consequent hyperglycemia (Alberti & Zimmet, 1998), is associated with increased 
risk of hypertension (Gress, Nieto, Shahar, Wofford, & Brancati, 2000), dyslipidemia 
(Goldberg, 2001), microvascular diseases (UK Prospective Diabetes Study Group, 1998), 
nontraumatic amputations (Shojaiefard, Khorgami & Larijani, 2008), and cardiovascular 
disease (Haffner, Lehto, Rönnemaa, Pyörälä, & Laakso, 1998). T2D accounts for 
approximately 95% of all diagnosed cases of diabetes nationally (Centers for Disease 
Control and Prevention [CDC], 2015). Moreover, according to the most recent Centers 
for Disease Control and Prevention (CDC) data, T2D is the seventh leading cause of 
death in the U.S. (Kochanek, Murphy, Xu, & Tejada-Vera, 2016), and adults with T2D 
have approximately a 180% greater risk of dying prematurely as compared to their non-
diabetic counterparts (Seshasai et al., 2011).  
In the United States alone, an estimated 21 million people have been diagnosed 
with T2D, and another 8.1 million are thought to be undiagnosed cases (CDC, 2015). The 
estimated economic cost of diabetes is $245 billion, with $69 billion attributed to indirect 
costs of the disease, including work-related absenteeism, unemployment due to chronic 
complications of the disease, loss of productivity at work, and premature mortality 
(American Diabetes Association [ADA], 2013). In 2007, the projected cost for 
undiagnosed diabetes alone was $8.3 billion (Zhang, Dall, Mann, et al., 2009). With an 
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estimated 1.4 million new cases of diabetes diagnosed annually (CDC, 2015), and 
predictions of nearly 1 in 3 adults being diagnosed by 2050 (Boyle, Thompson, Gregg, 
Barker, & Williamson, 2010), it is increasingly important to identify and implement those 
health care pathways that effectively reduce T2D incidence in order to both improve 
health and reduce national health care costs.  
Like T2D, prediabetes places an individual at substantially higher risk of heart 
disease, stroke, vision loss, amputations, kidney disease, and early mortality (Albright & 
Gregg, 2013; Nathan et al., 2007). Moreover, as compared to the 1% annual risk of T2D 
among the general population, the average annual risk of developing T2D among those 
with prediabetes is 5%-10% (Gerstein et al., 2007). Prediabetes is diagnosed when an 
individual has elevated blood glucose levels that are below the clinical cutoff of frank 
diabetes. Eighty-six million people in the U.S. are thought to have prediabetes (CDC, 
2015), accounting for an estimated $25 billion in health care costs (Zhang, Dall, Chen, et 
al., 2009). While prediabetes represents a substantial health care burden in and of itself, it 
also identifies individuals who may benefit most from targeted diabetes-prevention 
efforts.   
The goal of usual care treatment for T2D is to achieve and maintain optimal levels 
of blood glucose, circulating lipids, and blood pressure so as to delay or prevent the 
development of comorbidities (ADA, 2010). Effective management of blood glucose and 
related health indices has been shown to occur through improved nutrition, increased 
physical activity, weight loss, and the use of prescription medications (CDC, 2015). The 
relative efficacy of these methods, however, is not well understood.  
The Diabetes Prevention Program (DPP) was a large randomized controlled trial 
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that compared the efficacy of an intensive lifestyle intervention with the use of 
metformin, a leading antidiabetes prescription medication, to reduce the incidence of 
T2D in individuals with impaired glucose tolerance (Knowler et al., 2002). The primary 
outcome, progression to T2D, was measured in addition to secondary cardiometabolic 
risk factors. The goals of the intensive lifestyle intervention (ILS) were modest weight 
loss of at least 7% of initial weight and an increase in moderate-to-vigorous intensity 
physical activity (MVPA) to at least 150 minutes per week. Over a period of 24 weeks, 
the ILS group attended 16 one-on-one “core sessions,” led by either a nutritionist, 
physician, or exercise expert, which focused on educating participants and improving 
their behaviors related to healthy eating, increasing exercise, and other common barriers 
to healthy lifestyle change (Knowler et al., 2002). Following the core sessions, the 
maintenance phase consisted of continued group and one-on-one sessions offered every 
4-6 weeks for the remainder of the nearly 3-year study period. The results of the study 
showed that, in comparison to a control group who only received standard health 
behavior education, the incidence rate of T2D was reduced by 58% and 31% in the ILS 
and Metformin groups, respectively. Fifty percent of the participants in the ILS group 
achieved the 7% weight loss goal by the end of the 24 weeks, while 74% attained the 
physical activity goal of at least 150 minutes of MVPA per week. Posthoc analysis of the 
ILS group data revealed that weight loss of 5 kg (11lb) reduced the risk of T2D by 51%, 
and for every kilogram lost, there was a 16% reduction in risk for T2D (Hamman et al., 
2006). Those who achieved both goals of the ILS reduced their risk of T2D by 89% 
(Hamman et al., 2006). The authors concluded that, in comparison to weight loss per se, 
the combination of diet and physical activity-induced weight loss elicited the greatest 
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improvement in risk for T2D.  
The Diabetes Prevention Outcomes Study (DPPOS) is a long-term follow-up to 
the DPP. The aim of the DPPOS was to identify whether or not the reduced risk for T2D 
that was observed in the original DPP intervention groups would persist over time 
(Diabetes Prevention Program Research Group [DPPRG], 2009). During a median 
follow-up period of 5.7 years, it was found that diabetes incidence rates rose in the 
lifestyle intervention group from 48 to 59 cases per 1000 person years, which may be 
partly explained by weight regain during this period (DPPRG, 2009). However, when 
compared with the placebo group, the 10-year cumulative incidence of T2D in the 
Lifestyle and Metformin groups was reduced by 34% and 18%, respectively (DPPRG, 
2009). Further analysis of the DPPOS revealed that those individuals who achieved a 
complete reversion to normal glucose regulation had a 56% lower risk for T2D as 
compared to participants who remained prediabetic for the duration of the follow-up 
study (Perreault et al., 2012). Moreover, regression to normal glucose regulation was 
associated with significantly lower cardiovascular disease risk, underscoring the 
cumulative benefits of long-term healthy lifestyle behavior change (Perreault et al., 
2014). 
The success of the DPP, which was in consort with other large diabetes 
prevention trials, is the basis of the CDC’s ongoing effort to translate healthy lifestyle 
intervention programs into real-world clinical care. Specifically, in 2009, the CDC’s 
Division of Diabetes Translation began work to establish the National Diabetes 
Prevention Program (NDPP), which was later included in the Patient Protection and 
Affordable Care Act (2010). The goals of the CDC’s implementation of the NDPP were 
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to standardize the training of the workforce responsible for teaching a version of the 
DPP’s lifestyle intervention that was modified for delivery to small groups (~10-18 
individuals) of at-risk individuals. Implementing the NDPP also established standards for 
program accuracy and reliability and created a central support system for community-
based organizations looking to disseminate the NDPP’s lifestyle program at the local 
level (CDC, 2016). To date, the CDC has fully recognized more than 80 NDPP programs 
across the country, with more than 1000 additional community programs pending 
recognition.  
In the state of Utah, 4.4% of the population has been diagnosed with T2D and 
32.7% of Utahans are thought to be prediabetic (Dall et al., 2014). Moreover, the 
estimated total cost related to diabetes was predicted at nearly 1.7 billion dollars, with 
272 million dollars being accounted for by prediabetes (Dall et al., 2014). Despite being 
one of the most active states in the nation, it is estimated that 56.9% of the state’s 
population are overweight, 22.5% are obese, and 48.1% do not get adequate physical 
activity (CDC, 2010). The University of Utah Diabetes Prevention Program (UUDPP) 
was developed as a pilot project to implement the CDC’s NDPP for at-risk members of 
the community. Though this pilot study was designed to initially target members of the 
University of Utah and their families, if successful, the architects of the study intend to 
expand the project to include members of the greater Salt Lake City region. The purpose 
of the current study is to evaluate and report the UUDPP’s efficacy to reduce the risk for 
T2D and improve cardiometabolic health among members of the University of Utah 
community who are at an elevated risk for developing T2D. Data from this year-long 
pilot project will be compared with similar worksite translational studies of the DPP 
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(Amundson et al., 2009; Mau et al., 2010) as well as those of the landmark Diabetes 
Prevention Program (Knowler et al., 2002) and will be used to guide expansion of the 
NDPP within the state of Utah. 
 
Study Aims and Hypotheses 
The purpose of this feasibility study was to determine the efficacy of the National 
Diabetes Prevention Program to reduce the risk for type 2 diabetes via improvements in 
body weight, body composition, and other markers of cardiometabolic health, and to 
improve quality of life in members of the University of Utah Community who are at 
elevated risk for developing type 2 diabetes. Therefore, we proposed the following aims:  
Aim 1: To determine whether 12-months of the National Diabetes Prevention Program 
lifestyle intervention reduces risk for type 2 diabetes by improving body weight, body 
composition, glucose regulation, blood pressure, physical activity, and quality of life. 
Hypothesis 1: We hypothesize that there will be significant reductions in type 2 
diabetes risk via improvements in body weight, body composition, glucose 
regulation, blood pressure, physical activity, and quality of life after 12 months of 
the National Diabetes Prevention Program lifestyle intervention. 
Aim 2: To determine whether those participants who achieve the weight loss or physical 
activity goals of the National Diabetes Prevention Program lifestyle intervention have 
greater improvements in body composition, glucose regulation, blood pressure, and 
quality of life as compared to those participants who do not achieve the intervention’s 
weight loss or physical activity goals.  
Hypothesis 2: We hypothesize that those participants who achieve the weight loss 
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or physical activity goals of the National Diabetes Prevention Program lifestyle 
intervention will have greater improvements in body composition, glucose 
regulation, blood pressure, and quality of life as compared to those participants 





REVIEW OF LITERATURE 
 
Prevention of Type 2 Diabetes 
The outcomes of the DPP study aligned with those of previous reports from the 
Malmö Feasibility Study, The Da Qing Diabetes Prevention Trial, and the Finnish 
Diabetes Prevention Study, each of which implemented similar behavior-based 
interventions in groups of individuals who were at high risk of developing T2D (Eriksson 
& Lindgärde, 1991; Pan et al., 1997; Tuomileto et al., 2001). Additionally, both the 
Finnish Diabetes Prevention Study and the DPP have elicited long-term follow-up data 
regarding the efficacy of the original interventions to promote sustained health 
improvements and persistent protection again T2D (DPPRG, 2009; Lindstrom et al., 
2006). Moreover, the DPP has prompted multiple translational studies and investigations 
into its efficacy in different racial and ethnic subsets of the U.S. population (Ackermann, 
Finch, Brizendine, Zhou, & Marrero, 2008; Kramer et al., 2009). Together, these studies 
are informing the clinical practice and public health care policies we now use to support 
those with prediabetes. Still, further research is warranted as rates of diabetes have yet to 
recede. 
Some of the earliest research targeting long-term T2D prevention came out of the 
Malmö Feasibility Study (Eriksson & Lindgärde, 1991). This 6-year prospective cohort 
study was designed to evaluate the feasibility of a clinical diet and exercise program to 
reduce the incidence of T2D in individuals with impaired glucose tolerance. Participants 
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were organized into diabetic and prediabetic treatment groups, in addition to prediabetic 
and normal controls. The treatment program consisted of 6 months of dietary counseling, 
and 6 months of physical activity instruction offered in groups of 10-15, or disseminated 
on an individual basis. After 5-years, the authors reported an average weight loss of 2.3-
3.3 kg, compared to an increase of 0.2-2.0 kg in the control, and a 63% lower risk of T2D 
among those in the intervention group as compared with controls (RR= 0.37, p < 0.003).  
Eriksson and Lindegärde (1991) concluded that the study’s combination of 
physical activity and weight reduction was effective at reducing risk of T2D development 
and improving the symptoms and complications of diagnosed diabetes, and could be 
maintained long term. The authors also proposed that this intervention could be translated 
to a large-scale community-based effort.  
The Da Qing Diabetes Prevention Trial (Pan et al., 1997) began shortly after the 
release of the Malmö study’s findings. At this time, the prevalence of diabetes in China 
was increasing rapidly in response to the country’s economic development and a greater 
predominance of modernized vs. traditional lifestyle (Pan, Yang, Li, & Liu, 1997). This 
controlled clinical trial aimed to examine the independent and combined effects of diet 
and exercise on incidence of T2D in those with impaired glucose tolerance in China (Pan 
et al., 1997). The goals of the dietary group were to restrict caloric intake for those with a 
BMI ≥ 25 kg/m2 so as to elicit weight loss at a rate of 0.5-1.0 kg/month until a BMI = 23 
kg/m2 was achieved. The exercise-only group was instructed to increase activity by 1-2 
units of exercise per day, with one unit equating to 30 minutes of mild, 20 minutes of 
moderate, 10 minutes of strenuous, or 5 minutes of very strenuous activity. The 
intervention goals for the diet and exercise combination group included both goals from 
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the diet- and exercise-only groups. All intervention groups received weekly counseling 
for 1 month, followed by monthly counseling for the following 3 months, and then once 
every 3 months for the remainder of the study. At the end of the 6-year study, results 
revealed a 67.7% incidence of diabetes in the control group, and 46% in the combined 
group. The diet-only and exercise-only groups also showed significantly lower incidence 
rates, 43.8% and 41.1%, respectively, indicating that either group was effective in 
reducing the incidence of diabetes. As compared with the control group, the diet, 
exercise, and combined intervention groups showed reductions in risk of 31%, 46%, and 
42%, respectively.  
Like China, Finland experienced a significant increase in the prevalence of T2D 
during the 1980s and 1990s, and it was estimated that there was a 97% increase in the 
number of individuals diagnosed with diabetes from 1988-2002 (Niemi & Winell, 2006). 
The Finnish Diabetes Prevention Study, which was published 4 years after the Da Qing 
Trial, was designed to determine the feasibility and efficacy of a lifestyle modification 
intervention to prevent the onset or delay T2D at the community level (Tuomileto et al., 
2001). In this study, participants were randomly assigned to treatment or control groups. 
Members of the treatment group received individual counseling on reducing weight by at 
least 5%, limiting total intake of fat to < 30% of total energy consumed, reducing intake 
of saturated fat to < 10% of the total energy consumed, increasing fiber consumption, and 
accumulating at least 30 minutes of moderate intensity exercise each day. Counseling 
sessions were offered 7 times throughout the year, with telephonic counseling provided 
every 3 months for the remainder of the intervention. Control group participants were 
given information on the goals of the intervention, but were not given any individualized 
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programming to help them accomplish those goals.  
After the 1st year, Tuomileto et al. (2001) found that the mean weight loss was 
greater in the intervention group as compared to the control group (4.7 ± 5.4% vs. 0.9 ± 
4.2%, p < 0.001). After 2 years, weight reduction remained significantly greater in the 
treatment group (p < 0.001). After the completion of the study and an average follow-up 
period of 3.2 years, the cumulative incidence rates of diabetes were 11% in the 
intervention group and 23% in the control group, which coincided with a 58% risk 
reduction in those who completed the intensive lifestyle modification intervention. This 
reduction in risk was identical to that of DPP, and in line with the 42% reduction in risk 
observed in the Da Qing’s combined exercise and diet modification group (Knowler et 
al., 2002; Pan et al., 1997). 
Similar to the DPPOS, the extended follow-up of the Finnish Diabetes Prevention 
Study was designed to assess the long-term effects of the lifestyle intervention and its 
sustained efficacy in reducing the development of T2D (Lindstrom et al., 2006). Results 
revealed that after a mean follow-up of 7 years, the cumulative incidence rate of T2D in 
the intervention group was 4.3 cases per 100 person years (95% CI 3.4–5.4), relating to a 
43% reduction in risk. Though there was a trend toward an increase in the overall risk of 
progressing to T2D following the initial intervention period, the absolute risk of the 
original group differences persisted  compared to follow-up.  
Further analysis of the Finnish Diabetes Prevention Study follow-up identified a 
positive association between the number of intervention goals achieved and the 
magnitude of the reduction in incidence of T2D over the 7-year period (Lindstrom et al., 
2006). Summarily, Lindstrom et al. (2006) found that those who achieved 4 or 5 of the 
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lifestyle modification goals of the original intervention reduced their risk for T2D by 
77% (HR = 0.23, p = 0.0004). Similarly, Hamman et al. (2006) found a positive 
relationship between the number of goals achieved in the DPP and improvement in risk. 
They concluded that achieving all of the DPP goals conferred an 89% reduction in risk 
for developing T2D (HR = 0.11, p < 0.0001). Of the existing large diabetes prevention 
studies, the Da Qing Trial was the only one to directly assess the isolated impact of 
exercise and diet on risk reduction. Interestingly, they found that a greater reduction in 
risk for diabetes was observed in the exercise-only group when compared to the diet or 
combined intervention groups (Pan et al., 1997). Specifically, they found that the 
exercise-only group experienced a 46% (p < 0.0005) reduction in risk of developing 
diabetes compared to the 42% (p < 0.005) reduction in the combined group, and 31% (p 
< 0.03) reduction in the diet-only group.  
Global estimates have indicated that several native and migrant Asian Indian 
populations in South Africa, India, Singapore, and Fiji are among those with the highest 
prevalence of diabetes and prediabetes (11->20%) (King & Rewers, 1993). The Indian 
Diabetes Prevention Program (IDPP) was developed in response to the earlier large 
diabetes intervention trials, with the aim to determine whether a lifestyle intervention 
could also be effective at reducing the rate of diabetes progression in an Asian Indian 
prediabetic population (Ramachandran et al., 2006). Participants with confirmed impaired 
glucose tolerance were randomized to one of four groups. Group 1, the control group, 
received health information and advice regarding the risk of progressing from prediabetes 
to T2D. Of the three intervention groups, Group 2 undertook a lifestyle modification 
intervention, Group 3 was given metformin, and Group 4 was given the combination of 
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both the lifestyle intervention plus metformin. The lifestyle group received advice about 
achieving at least 30 minutes of moderate intensity physical activity per day, nutritional 
advice about dietary modifications for the reduction of total caloric intake, and guidelines 
on how to make healthier eating choices (Ramachandran et al., 2006). Unlike previous 
lifestyle interventions, no specific weight loss goal was given. Monthly phone calls and 
in-person coaching sessions provided every 6 months were provided to all participants 
receiving the lifestyle intervention (Groups 2 and 4), for the duration of the study 
(Ramachandran et al., 2006). Following the 3-year intervention period, the cumulative 
incidences of T2D was 55% in the control group (95% CI 46.0-63.6), 39.3% (95% CI 
30.4-48.5), 40.5% (95% CI 32.0-49.7), and 39.5% (95% CI 30.9-48.9) in the intervention 
alone, the metformin, and the combined intervention groups (Groups 2, 3, and 4), 
respectively (Ramachandran et al., 2006). Though effective at reducing diabetes 
incidence, there were no significant differences between intervention groups, with risk 
reductions of 26.4-28.5% when compared with the control group. Though a significant 
increase in weight from baseline was observed in the control group (p < 0.01), an 
increase in weight was also observed in the intervention only group (Group 2) at 24 
months (p = 0.035) despite their reduced risk for T2D. There were no significant weight 
changes in the other groups (p > 0.05) (Ramachandran et al., 2006).   
Though the IDPP (Ramachandran et al., 2006) resulted in significant reductions in 
the progression to T2D among prediabetic participants, the magnitude of the effect of the 
lifestyle intervention (28.5%) was markedly less than that from the other large diabetes 
prevention studies. The overall risk reductions of 58% in both the Finnish and DPP 
studies and the 42% reduction in risk from the Da Qing study all provided stronger 
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evidence for effective primary prevention of T2D (Knowler et al., 2002; Pan et al., 1997; 
Tuomileto et al., 2001). As the authors of the IDPP noted, the rate of progression from 
prediabetes to diabetes was significantly higher in the Indian controls (18.3% per year) as 
compared with the controls of the Finnish (6% per year), the DPP (11%), and the Chinese 
Da Qing control groups (11.3%) (Ramachandran et al., 2006). It should also be noted that 
the IDPP did not employ a weight loss goal among its intervention groups. Considering 
that weight loss was established as the most important factor in the reduction of risk 
observed in the Finnish and DPP studies, the subsequent lack of weight loss among the 
intervention groups in the IDPP may partially explain the reduced effectiveness in the 
IDPP’s intervention as compared with those of the Finnish Diabetes Prevention Study 
and the American DPP (Knowler et al., 2002; Ramachandran et al., 2006; Tuomileto et 
al., 2001). 
 
Scaling up the DPP 
Despite an impressive reduction in T2D risk following implementation of an 
intensive lifestyle intervention, the DPP was not designed as a cost-effective model for 
large-scale dissemination of diabetes prevention practices. Rather, the DPP was a time 
and resource-intensive intervention that provided, among other aides, fitness facility 
access and one-on-one counseling and has been estimated to cost $1,399 per participant 
(Ali, Echouffo-Tcheugui & Williamson, 2012; Knowler et al., 2002). Several translation 
studies have been conducted to investigate how to modify the DPP ILS for community-
level application. The DEPLOY study assessed the feasibility of training existing YMCA 
wellness instructors to deliver a group-based adaptation of the original “core sessions” of 
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the DPP (Ackermann, Finch, Brizendine, Zhou, & Marrero, 2008). After 12 months, 
participants exhibited significantly greater reductions in body weight (-6% vs. baseline, p 
< 0.05) and improvements in total cholesterol (-13.5 mg/dl vs. baseline, p < 0.05) as 
compared to controls that participated in usual YMCA wellness programming. Moreover, 
the magnitude of weight lost was in line with the original, more intensive DPP study 
(Knowler et al., 2002). Another study assessed the viability and effectiveness of a clinic-
based system of patient-referral to community-based lifestyle intervention programs 
(Ackermann, 2010). Ackermann (2010) found that a two-stage screening process to 
identify high risk individuals, and clinical testing of both fasting and 2-hour oral glucose 
tolerance, were deemed feasible even for the large volume of potential participants. 
Additionally, Ackermann et al. (2006) reported that economic modeling of these group-
based practices and screening procedures indicated that even if these large-scale 
community-level efforts prove to be only half as effective as the original DPP, the 
outcomes would still likely be cost effective. 
 
Mechanisms Underlying the NDPP’s Lifestyle Intervention 
The goals of the DPP were twofold: weight loss and increased physical activity. 
Specifically, participants were encouraged to achieve and maintain weight loss of 7% of 
baseline body weight through modifications in both diet and exercise (Knowler et al., 
2002). Initial dietary modification included the reduction of total fat intake, not caloric 
restriction per se. However, this change in fat intake was intended to promote a 
consequent caloric deficit through healthier eating habits (DPPRG, 2002). Targeted 
caloric-reduction goals were introduced several weeks after the initial dietary 
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modification phase, and they tasked participants with reducing total caloric intake by 
500-1000 kcal per day so as to achieve weight loss of approximately 1-2 pounds per 
week. To help them reach these goals, participants were taught strategies for self-
monitoring of fat and calorie intake, healthier food selection and preparation, and 
restaurant choice. These dietary modifications coincide with the National Institutes of 
Health clinical guidelines for weight loss and the reduction of cardiovascular disease risk 
in overweight and obese adults (Klein et al., 2004; Pi-Sunyer et al., 1998).  
The other primary goal of the DPP was to increase participant physical activity to 
at least 150 minutes of moderate intensity exercise per week. This physical activity goal 
was designed to incur a weekly exercise energy expenditure of at least 700 kcals 
(DPPRG, 2002). This physical activity goal was chosen because previous research has 
supported its effectiveness for the prevention of T2D and its sustainability in long-term 
prospective studies (DPPRG, 2002; Helmrich, Ragland, Leung, & Paffenbarger, 1991; 
Wing et al., 1988). Moreover, this volume of physical activity is in line with current 
national recommendations for the purpose of reducing risk for cardiovascular and 
metabolic diseases and the prevention of unhealthy weight gain (Haskell et al., 2007; Pate 
et al., 1995; Physical Activity Guidelines Committee, 2008). 
The DPP’s Steering Committee designated weight loss and increased physical 
activity as the primary focus of the program’s lifestyle modification efforts in direct 
response to the outcomes of the Malmö Study (DPPRG, 2002), which reported that 
weight loss and improved cardiorespiratory fitness were significantly and independently 
correlated with improvements in insulin sensitivity. Moreover, the Malmö study found 
that the improvements in fitness and body weight contributed equally to the reductions in 
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T2D incidence with partial correlations (r2) of 0.04 (p < 0.03) and 0.05 (p < 0.011) for 
weight loss and increased oxygen consumption, respectively (Eriksson & Lindgarde, 
1991). In contrast, the DPP Study (Hamman et al., 2006), and the Finnish Diabetes 
Prevention Study (Tuomileto et al., 2001) established that weight loss per se was the most 
important factor for the prevention of T2D in individuals with impaired glucose tolerance 
or prediabetes. In a posthoc analysis of the DPP intensive lifestyle group, Hamman et al. 
(2006) determined that diabetes risk was not affected by either the average annual change 
in self-reported physical activity (MET hours/week) or average reduction in caloric 
intake (total kcal/day) when these variables were assessed independently of weight loss. 
However, in those individuals who did not meet the weight loss goal, successfully 
meeting the physical activity goal still conferred a 44% reduction in T2D incidence (p = 
0.012). Similarly, in the Finnish Diabetes Prevention Study, Tuomileto et al. (2001) 
reported a 70% reduction in the incidence of T2D in those participants who did not lose 
more than 5% of their body weight but who did achieve the goal of getting more than 4 
hours per week of moderate intensity exercise. Further analysis of the Finnish study 
found that obtaining at least 2.5 hours/week of walking conferred a 63-69% decrease in 
T2D risk, which was independent of BMI (Laaksonen et al., 2005). Furthermore, the odds 
ratio for developing T2D for those subjects in the intervention group who did not reach 
the 5% weight loss goal but did achieve the exercise goal during the first year was 0.2 
(95% CI, 0.1-0.6) (Laaksonen et al., 2005). Moreover, the authors of the Malmö Study 
indicated that those in the intervention group who lost weight and improved their 
cardiorespiratory fitness were reported to have greater reductions in T2D risk as 
compared to those who achieved only weight loss or improved fitness (Eriksson & 
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Lindgarde, 1991). Thus, though weight loss is not essential to improve risk for diabetes, 
there appears to be a dose-response relationship between the magnitude of improvement 
in body weight and physical activity, and the diabetes-preventive effect of intensive 
lifestyle modification. 
The mechanisms by which physical activity confers improvements in glucose 
metabolism underlie the independent effects of exercise on T2D incidence. At rest, 
insulin is required to facilitate the removal of glucose from the blood and its intake into 
the cells of the body for storage and use for energy (Alberti & Zimmet, 1998). Muscle 
tissue is the principle site of this insulin-mediated glucose “disposal,” and glucose 
transport across the cellular membrane into the muscle has been identified as a rate-
limiting step for glucose uptake in both normal and diabetic subjects (Shepherd & Kahn, 
1999). As such, dysfunction of any of the processes involved in insulin-mediated glucose 
uptake by skeletal muscle substantially increases an individual’s risk of hyperglycemia 
and subsequent diabetes. In fact, muscle insulin resistance, which is characterized by 
impaired glucose transport into the muscle tissue, is a significant predictor of subsequent 
T2D (Haffner, Lehto, Rönnemaa, Pyörälä, & Laakso, 1998). During contraction (i.e., 
physical activity and exercise), however, muscle tissue is able to take up glucose from the 
blood independent of insulin. Even in insulin-resistant T2D, glucose uptake by the 
working muscle is preserved via contraction-related glucose transport function (Goodyear 
& Kahn, 1998; Musi et al., 2001). Therefore, muscle action during physical activity 
represents a key moderator in acute glucose management and an important component in 
lifestyle modification for both the prevention and treatment of T2D.  
Acute and chronic exercise has been shown to increase insulin sensitivity in 
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muscle, adipose, and liver tissue, thus improving systemic glucose metabolism even at 
rest (Goodyear & Kahn, 1998). Devlin et al. (1987) reported increases in insulin 
sensitivity following acute bouts of vigorous intensity endurance exercise, while 
Perseghin et al. (1996) reported improvements in glucose uptake of up to 40% in 
response to endurance exercise-induced glucose transport into muscle tissue. However, 
these benefits have been shown to diminish quickly, with insulin sensitivity decreasing 
48-72 hours following the last bout of exercise (King et al., 1995).  
Reductions in the highly metabolically active visceral adipose tissue depot are 
mechanistically linked with increases in insulin sensitivity following weight loss (Kahn, 
2003). Visceral adiposity promotes increases in circulating nonesterified fatty acids, 
ectopic fat deposition and proinflammatory cytokines (TNF-α, IL-6), which are thought 
to impair insulin-receptor function and subsequent insulin-mediated glucose uptake in a 
variety of tissues, including adipose, muscle, pancreas, and liver (Johnson et al., 2009; 
Petersen & Pedersen, 2009). Fortunately, visceral fat appears to be particularly sensitive 
to exercise-induced sympathetic stimulation of lipolysis and is preferentially mobilized 
(and thus reduced) in response to exercise training even when exercise does not elicit 
changes in body weight (Johnson et al., 2009; Vissers et al., 2013).  
In addition to its direct effects on insulin sensitivity, physical activity significantly 
impacts the most common comorbidities of T2D. Observational studies have shown that 
endurance, resistance, or a combination of endurance and resistance exercise can reduce 
blood pressure in those with diabetes (Cauza et al., 2005; Cohen et al., 2008). Cauza et al. 
(2005) demonstrated positive effects of exercise on blood pressure with as little as 90 
minutes of MVPA per week, which is below the dose of exercise employed by the DPP. 
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Additionally, exercise has been associated with reductions in very low-density 
lipoprotein (VLDL) and triglyceride levels, and substantial increases circulating high-
density lipoproteins (HDL) (Department of Health and Human Services [DHHS], 1996; 
Kraus et al., 2002). Though the biggest improvements in blood lipids have been observed 
following high-volume exercise, positive changes have been observed at doses similar to 
that of the DPP, including improvements in low-density lipoprotein (LDL) particle size 
and triglyceride concentrations (Kraus et al., 2002).  
Current national physical activity recommendations (150 minutes per week of 
moderate activity or 75 minutes a week of vigorous activity), which are in line with the 
physical activity goals of the DPP, aim to prevent unhealthy weight gain and reduce risk 
for chronic diseases including cardiovascular disease and T2D (Physical Activity 
Advisory Committee, 2008). Without concomitant reductions in caloric intake, however, 
larger volumes of activity are likely needed for clinically relevant weight loss of 5% or 
more, and though the exact dose (or volume) of physical activity required to prevent T2D 
is not yet known, data from the Nurses’ Health Study, the Iowa Women’s Health Study, 
the Study of Eastern Finns, and the DPP suggest that approximately 150 minutes of 
moderate intensity exercise reduces the risk for T2D by 25-36% (Physical Activity 








We used an experimental research design to determine the effects of the 12-month 
UUDPP lifestyle intervention on our dependent variables, which included changes in 
body weight, waist and hip circumferences, blood pressure, quality of life, physical 
activity, fasting blood glucose, serum HbA1c, and 2-hour oral glucose tolerance test 
(OGTT). Each of our dependent variables was measured at baseline and at the completion 
of the 12-month intervention. Our main independent variable was participation in the 
UUDPP lifestyle intervention. In a secondary analysis, we explored changes in the 
association between our dependent variables according to whether participants did or did 
not meet the weight loss and physical activity goals of the NDDP intervention (secondary 
independent variables).    
 
Participants 
 Members of the University of Utah faculty and staff and their immediate family 
who were at high risk for developing T2D were recruited to volunteer to participate in 
this study. Volunteers were overweight or obese (BMI ≥ 24 kg/m2, or ≥ 22 kg/m2 if 
Asian), and were given physician’s clearance to participate in onsite-supervised exercise. 
Qualified volunteers were screened to determine their risk for T2D by completing the 
CDC prediabetes-screening test, which provided a risk score in response to questions 
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regarding risk of gestational diabetes, family history, BMI, and age. A score ≥ 9 indicated 
high risk for prediabetes. According to CDC NDPP administrative guidelines (CDC, 
2011), at least 50% of participants had to be diagnosed as prediabetic according to one of 
the following methods: 2-hour OGTT (plasma glucose 140-199 mg/dl), fasting plasma 
glucose (100-125 mg/dl), or Hemoglobin A1c (HbA1c) (5.7-6.4). Accordingly, no more 
than 50% of the participants could qualify with a CDC prediabetes screening test score ≥ 
9 without qualifying blood values. Volunteers previously diagnosed with gestational 
diabetes mellitus automatically qualified for participation even if they did not present 
with current indicators of prediabetes.  
 Exclusion criteria included diagnosis of T2DM, pregnancy, lack of medical 
clearance for participation, severe cardiac disease (New York Heart Association class III 
or greater), uncontrolled hypertension (> 165/95 mmHg), and any orthopedic problems 
that would preclude participation in the physical activity intervention. Participants were 
required to be willing to undergo screening tests, including tests of fasting blood sugar, 
oral glucose tolerance, blood lipids, and Hemoglobin A1c. 
 
Recruitment and Participant Identification 
 Recruitment was started following approval by the University of Utah 
Institutional Review Board. Flyers and study information were disseminated to 
University Hospital and campus departments/divisions through in-person discussions 
with faculty and staff, and via an informational video intended for use during staff/faculty 
meetings. Medical providers at the University of Utah also referred patents for study 
participation. The email address dpp@utah.edu was used on all fliers and recruitment 
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materials, and all prospective volunteers were directed to contact the UUDPP email.  
All interested volunteers were contacted via phone by a study lifestyle coach for 
prescreening. The phone-based prescreening process was standardized by the NDPP 
(CDC, 2011), and was used to identify risk of T2D (see Appendix). Qualified volunteers 
were invited to attend an in-house screening at the University of Utah (at either HPER-
East or the Health Professions Education Building) to further discuss the study details, 
provide answers to any volunteer questions, and to obtain informed consent. Paper copies 
of all signed informed consent documents, which included contact information for study 
administrators, were supplied to enrolled participants. If the volunteer did not wish to 
provide consent to study participation, she/he was invited to participate in the Diabetes 
and Senior Health (DASH) supervised exercise program as well as the nutrition and 
behavior modification education classes offered at the University of Utah through the 
PEAK Health and Fitness clinic.  
 
Procedures 
Upon receiving signed informed consent, demographic information, including 
contact and address information, ethnicity, race, marital status, living situation, education 
level, and employment status, was collected and participants were scheduled for a 
subsequent appointment at the University of Utah Hospital’s Center for Clinical and 
Translational Science (CCTS), where they underwent fasting tests of blood glucose, 
serum HbA1c and a 2-hour OGTT, in accordance with the CDC guidelines (CDC, 2014). 
This appointment required participants to fast for the 12 hours preceding their 
appointment. Appointments were scheduled for approximately 3 hours so as to provide 
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adequate time for arrival and orientation, participant questions, and all necessary testing 
procedures. Participants were offered a meal following their OGTT. The CCTS sent all 
test results to the principle investigator or co-investigator via encrypted email.  
 Participants with prediabetes confirmed by either the CDC Prediabetes Screening 
Test (see Appendix) or by qualifying blood testing were contacted by a UUDPP research 
assistant or Lifestyle Coach to schedule an appointment for baseline testing. At this 
appointment, a UUDPP Lifestyle Coach collected information on the participant’s 
medical history and biometric data, measured their cardiovascular fitness, and guided the 
participant on how to complete surveys of their quality of life, dietary intake, and self-
report physical activity. Resting heart rate was calculated via radial pulse for 30 seconds, 
multiplying the counted heart rate by two. Body weight (kg) was assessed using a self-
calibrating digital scale (Seca 840 Bellissima-digital, Snoqualmie, WA), and height was 
measured via stadiometer (Seca 216 Accuhite, Snoqualmie, WA). To determine the 
weight loss goal that would be incorporated in the lifestyle intervention program, 7% of 
baseline weight was calculated per the NDPP guidelines. Resting blood pressure was 
measured using a standard aneroid sphygmomanometer and stethoscope. Waist and hip 
circumferences were measured in accordance with WHO guidelines (World Health 
Organization [WHO], 2011), and a waist-to-hip ratio was calculated. To estimate 
cardiovascular fitness, a 6-minute walk test was administered (Enright, 2003). This test 
was used because it is perceived as safe, easy to measure, and applicable to an 
ambulatory obese population (Beriault et al., 2009). Additionally, participants were 
instructed on and completed three survey instruments. All surveys are included in the 
Appendix. The validated Rapid Assessment of Physical Activity (RAPA) assessed 
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participants’ self-reported physical activity levels (Topolski, et al., 2006). Two 
assessments of quality of life, the Quality of Life Scale (QOLS) and the Single Item 
Quality of Life, were administered (Burckhardt & Anderson, 2003), as management and 
lowering of blood glucose levels has been shown to be effective in improving overall 
wellbeing or quality of life (Rubin & Pevrot, 1999). The quality-of-life scales were 
evaluated based on the sum score of all responses. The baseline appointment took 
approximately 1 hour. The follow-up appointment at approximately 12 months consisted 
of the same battery of tests as baseline, including blood testing. 
 
UUDPP Intervention 
 Following baseline testing, participants were assigned to a group of no more than 
15 participants. Groups were scheduled to attend 22 education classes at either the Health 
Professions Education Building (HPEB), the Annex building, Human Resources building, 
or Orson Spencer Hall at the University of Utah. The curriculum of the group education 
classes was developed by the CDC to target physical activity, healthy eating, and other 
healthy behavior modifications. The classes were led by trained and certified CDC NDPP 
Lifestyle Coaches. Classes were provided via weekly sessions for the first 8 weeks 
(classes 1-8), followed by bimonthly sessions for the following 4 months (classes 9-16). 
During the final 6 months, groups met only once per month (classes 17-22). At the 
beginning of each class, participants were asked to report total minutes of moderate 
intensity physical activity performed during the previous week. At study completion, an 
average of self-reported weekly physical activity during the last 6 months of the 
intervention was used to determine whether participants had reached their physical 
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activity goal of > 150 min of MVPA per week. Lifestyle Coaches also measured and 
recorded participant weight, and collected their food recall journals for subsequent 
review. The coaches encouraged participants to work toward the goals of 7% weight loss 
and to increase physical activity to at least 150 minutes of moderate intensity activity 
throughout the group education and discussion sessions, and through any individual 
contact they had with the participants during the intervention period.  
 Optional supervised exercise sessions were made available to participants each 
Tuesday and Thursday from 3:00-8:00 PM via the DASH exercise program held at the 
Skaggs Patient Wellness Center. Participants were encouraged to exercise on their own in 
this environment; however, additional instruction was available. Those who chose not to 
participate in the supervised physical activity were instructed to exercise on their own 
time. Those who did participate in the DASH supervised exercise program were 
instructed to acquire additional activity minutes on their own so as to meet the 
intervention’s physical activity goal.  
 
Sample Size Justification and Study Attrition 
Using a priori estimates, a total sample size of 46 was chosen to detect significant 
intervention-related change in body weight (Amundson et al., 2009) with a statistical 
power of 80% and at an alpha level of 0.05. This variable was selected due to the 
relationship between weight change and improvements in glucose regulation 
demonstrated by the large diabetes prevention trials previously reviewed. Though we 
oversampled and enrolled a total of 69 participants so as to accommodate anticipated 
drop out, we experienced an attrition rate of 32% and were left with 47 participants at 
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study completion. Participant flow through the enrollment, follow-up, and analytical 
phases of the study is presented in detail in Figure 1. Herein, we present data analysis for 
the 47 participants with complete weight and body composition data. Of these, we report 
missing data for one participant in each, the 6-minute walk distance and HbA1c 
measures. Similarly, two participants did not have complete fasting blood glucose data, 
and three participants were missing 2-hour OGTT data.  
 
Statistical Methods, Data Analysis, and Interpretation 
Descriptive statistics were used to determine the normality of our primary 
dependent variables, including body weight, BMI, waist circumference, waist-to-hip 
ratio, blood pressure, 6-minute walk distance, QOL, and fasting tests of blood glucose, 
serum HbA1c, and 2-hour OGTT. To determine the effect of participation in the 12-month 
diabetes prevention program on these variables, paired t-tests were used for normally 
distributed variables, and Wilcoxon Signed Rank tests for those variables that did not 
meet the assumptions of the parametric t-test. To summarize the responses of our 
dependent variables, change scores were calculated as postintervention score minus 
preintervention score. 12-month changes in data from the RAPA, which elicits yes or no 
answers to a series of 9 questions about participant physical activity habits, was assessed 
using the McNemar Test for differences on a dichotomous dependent variable between 
two related groups. To determine if achievement of the intervention’s weight loss or 
physical activity goals resulted in group differences in changes in body composition, 
glucose regulation, blood pressure and quality of life, we used a repeated measures 
analysis of variance with the preintervention values as covariates so as to control for any 
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regression to the mean effects. Spearman Rho correlations were used to assess bivariate 
relationships between those variables that were not normally distributed; Pearson Product 
Moment correlations were used for all other variables. A p-value < 0.05 was used to 
designate statistical significance. Posthoc calculations of effect-size and statistical power 
were performed to determine practical significance and the likelihood of Type-II error, 
respectively.  
 
 Figure 1. Participant flow diagram 






Participant demographics are presented in Table 1. Of the 47 total participants, the 
majority were female (78.7%), non-Hispanic/Latino (91.5%), and White (97.9%). The 
mean age of participants was 47.71 ± 11.15, and nearly half (42.6%) were educated at the 
bachelor’s degree level.  
In response to the 12-month long NDPP lifestyle intervention, there were 
significant improvements in body weight (-4.82%, p < 0.001), BMI (-5.20%, p < 0.001), 
waist circumference (-4.56%, p < 0.001), hip circumference (-4.50%, p < 0.001), systolic 
blood pressure (-5.94%, p < 0.001), 6-minute walk distance (7.15%, p = 0.001), and 
OGTT (-8.41%, p < 0.028; Table 2). By contrast, there were no significant changes in 
waist-to-hip ratio, diastolic blood pressure, and fasting blood glucose (Table 2). 
Additionally, there was a significant increase in serum HbA1c (1.45%, p = 0.035; Table 
2). Over the course of the 12-month intervention, the proportion of participants who met 
national physical activity recommendations by engaging in at least 30 minutes per day of 
moderate intensity physical activity on at least 5 days each week increased from 15% at 
baseline to 52% at study completion (p = 0.001; Figure 2). Similarly, the proportion of 
participants who engaged in strength training at least 1 day per week increased from 34% 
to 60% (p = 0.002), and the proportion of participants who performed activities to 
improve flexibility also increased from 43% to 67% (p = 0.001; Figure 2). Pairwise 
analysis of the QOLS revealed a significant increase in quality of life (p < 0.001), while 
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no change was observed in the single-item QOL (p = 0.47; Table 2). 
In evaluating the degree to which participants were successful during the UDPP, 
we assessed whether or not participants met the study’s goals for weight loss (lose 7% of 
baseline body weight) and/or physical activity (achieve and maintain 150 minutes of 
MVPA each week). We determined that 10 participants successfully achieved both goals, 
3 participants achieved the weight loss but not the physical activity goal, 29 participants 
achieved the physical activity but not the weight loss goal, and 5 participants were not 
able to achieve either goal. As a result, we had significant group size differences and 
small sample sizes that precluded statistical group comparisons. As an alternative, we 
used the Spearman Rho correlation coefficient to assess the bivariate association between 
the number of goals met given as a continuous variable and the change in all biometric 
and glucose variables. In this analysis, we found a significant positive correlation 
between the number of goals met and improvements in body weight (rS = 0.61, p < 
0.001), BMI (rS = 0.56, p < 0.001), waist circumference (rS = 0.39, p = 0.007), and hip 
circumference (rS = 0.33, p = 0.024). However, we found no statistically significant 
relationships between the number of goals met and any of the markers of glucose 



















Table 1. Baseline characteristics of participants completing lifestyle intervention 
 
Characteristics N = 47 
Sex  
Male, n (%) 10 (21.3) 
Female, n (%) 37 (78.7) 
Age, mean ± SD 47.71 ± 11.15 
Ethnicity   
Hispanic/Latino, n (%) 4 (8.5) 
Not Hispanic/Latino, n (%)  43 (91.5) 
Race  
White, n (%) 46 (97.9) 
Asian American, n (%) 1 (2.1) 
Marital Status  
Single, n (%) 9 (19.1) 
Married, n (%) 29 (61.7) 
Divorced, n (%) 8 (17.0) 
Widowed, n (%) 1 (2.1) 
Living Situation  
Lives alone, n (%) 4 (8.5) 
Lives with spouse, n (%) 18 (38.3) 
Lives with partner, n (%) 2 (4.3) 
Lives with spouse and children, n (%) 11 (23.4) 
Lives with children, n (%) 3 (6.4) 
Lives with other, n (%) 9 (19.1) 
Education Status  
High school or GED, n (%) 2 (4.3) 
Some college or technical school, n (%) 8 (17.0) 
Associates degree, n (%) 6 (12.8) 
Bachelor's degree, n (%) 20 (42.6) 
Master's degree, n (%) 7 (14.9) 
PhD degree, n (%) 3 (6.4) 
Other advanced degree, n (%) 1 (2.1) 
 












Table 2. Changes in weight, body composition, blood pressure, cardiorespiratory fitness, 
fasting blood glucose, 2-hour OGTT, HbA1c and quality of life following 12 months of 
UDDP intensive lifestyle intervention. (Values are means ± SD) 
 
Variable N Baseline Follow-up p-value 
Weight (kg) 47 99.71 ± 25.00 94.90 ± 24.05 <0.001a 
BMI (kg/m2) 47 35.59 ±7.48 33.74 ±7.13 <0.001a 
Waist (cm) 47 108.78 ± 18.92 102.82 ± 17.61 0.001a 
Hip (cm) 47 121.81 ± 17.74 116.33 ± 15.65 <0.001a 
Waist:Hip Ratio 47 0.89 ± 0.11 0.89 ± 0.11 0.958 
SBP (mmHg) 47 125.83 ± 12.21 118.36 ± 10.67 <0.001 
DBP (mmHg) 47 78.74 ± 10.94 76.77 ± 7.86 0.21 
6-minute walk (m) 46 512.28 ± 85.59 548.94 ± 77.22 0.001a 
FBG (mg/dL) 45 93.65 ± 8.90 92.22 ± 7.80 0.20a 
2-Hr OGTT (mg/dL) 44 122.41 ± 36.17 112.12 ± 25.83 0.03 
HbA1c (%) 46 5.53 ± 0.31 5.61 ± 0.27 0.04 
QOLS (score) 47 70.11 ± 11.45 75.91 ± 10.08 <0.001 
S-I QOL (score) 47 2.80 ± 0.69 2.87 ± 0.58 0.47a 
 
SBP-systolic blood pressure, DBP-diastolic blood pressure, FBG- fasting blood glucose, 
OGTT-oral glucose tolerance test, HbA1c-glycated hemoglobin A1c, QOLS-Quality of life 
scale, S-I QOL-single-item quality of life. 
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The purpose of this study was to determine whether a year-long diabetes 
prevention program, based on the guidelines of the National Diabetes Prevention 
Program, would be effective in improving glucose regulation, body composition, body 
weight, blood pressure, physical activity, and quality of life in those at high risk for 
developing T2D at the University of Utah. To our knowledge, this study is only the 
second diabetes prevention program translation study in the state of Utah, and the first to 
be conducted for higher education staff and faculty.  
The primary finding from this study was that, following the lifestyle intervention, 
participants experienced improvements in measures of body weight and body 
composition, blood pressure, physical activity status, and quality of life. Our second aim 
was to determine whether those who achieved one or more of the study goals (weight loss 
and increased physical activity) would achieve greater improvements in these dependent 
variables as compared with those who did not achieve the study goals. Though we were 
unable to detect group differences, we identified a direct relationship between the number 
of study goals achieved and the degree of improvement in body weight, BMI, and waist 
and hip circumferences.  
 The average weight loss of the participants in the current study was 4.8%, which 
was lower than that observed in the lifestyle intervention groups of the DPP (6.9%) and 
Finnish Diabetes Prevention Study (7.2%), respectively (Knowler et al., 2002; Tuomileto 
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et al., 2001; Figure 3). However, our findings align well with those from other DPP 
translational studies, which reported weight losses of 1.5% to 6.7% (Aldana et al., 2005; 
Amundson et al., 2009; Kramer et al., 2009; Whittemore et al., 2009; Figure 4). Though 
each of these studies was based on the original DPP, only the studies by Aldana et al. 
(2006) and Kramer et al. (2009) conducted follow-up testing at 1 year, while the others 
reported outcomes measured at 6 months of follow-up (Amundson et al., 2009; 
Whittemore et al., 2009). Though our reported average weight loss was small, the DPP 
established that even a small amount of weight loss strongly predicts improvements in 
T2D risk, with a 16% reduction in risk for every kg of lost weight (Hamman et al., 2006).  
In comparison to other translational studies, Mensink, Feskens, Saris, De Bruin, 
and Blaak (2003) and Aldana et al. (2005) saw significant reductions in glucose tolerance 
following a lifestyle intervention program. Significant improvement in glucose tolerance 
was also observed in the current study, though no significant changes were observed in 
fasting glucose values, and a significant increase in HbA1c was detected.  
The CDC’s criteria for enrollment in translational programs employing the NDPP 
are quite broad, presumably for the purpose of improving public health. By making 
inclusion in these community-based programs fairly lenient, a greater number of 
individuals may benefit from the program’s healthy lifestyle modifications. 
Unfortunately, though, these criteria have the potential to limit the ability to research the 
efficacy of these programs without an epidemiological scale sample size. In posthoc 
analyses looking at potential differences based on how participants were screened for 
prediabetes, we grouped subjects on the basis of whether or not they met the clinical 
diagnostic criteria for prediabetes (2-hr OGTT = 140-199 mg/dl, fasting plasma glucose = 
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100-125 mg/dl, or HbA1c = 5.7-6.4). We found that 52% of our participants met at least 
one of these clinical criteria. The remaining participants (n = 21) were designated as 
prediabetic, and thus eligible for study participation, according to the CDC’s screening 
instrument, which includes current weight, age, and family history of T2D. In comparing 
these groups, we found that those with clinically diagnosed prediabetes were older (p = 
0.003) and had higher baseline values for fasting glucose (p = 0.005), 2-hr OGTT (p = 
0.007), and HbA1c (p < 0.001). Despite covarying for these baseline group differences, 
there were no differences between groups for change in weight, BMI, waist or hip 
circumferences, blood pressure, 6-minute walk distance, fasting glucose, or 2-hr OGTT 
following the 12-month lifestyle intervention (p > 0.05). However, we did detect 
significant group differences for change in HbA1c (p < 0.002). Specifically, we found 
that those with clinically confirmed prediabetes experienced no significant changes in 
their HbA1c levels following the intensive lifestyle intervention. In contrast, those 
diagnosed as prediabetic using the CDC screening instrument experienced a significant 
increase in HbA1c following the intervention (p = 0.003). Though this represents only a 
2.6% increase (0.1359 points) in HbA1c levels, it is interesting to note these group 
differences. It is possible that, when compared with those who may not be clinically 
prediabetic, individuals with clinically confirmed prediabetes may be more sensitive to 
the metabolic improvements that can occur as a result of participation in the lifestyle 
intervention. As such, it may be inappropriate to utilize clinical measures of glucose 
management to evaluate the efficacy of the NDPP in participants without clinically 
confirmed prediabetes. Why those individuals who qualified for study participation via 
the CDC’s screening instrument alone experienced deterioration of their glucose 
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management as measured by the increase in HbA1c levels remains unclear and further 
investigation is warranted. 
 The effect of achieving the NDPP’s study goals on participant health outcomes 
was investigated by Hamman et al. (2006). In their posthoc analysis of the DPP, the 
authors determined that achieving all of the goals of the DPP proved most effective at 
reducing risk of T2D. Specifically, Hamman et al. (2006) found that there was a 46% 
reduction in T2D risk for participants who met the physical activity goal only, nearly an 
80% reduction for those who achieved the weight loss goal only, and an 89% reduction in 
risk for those who achieved all goals of the DPP (Hamman et al., 2006). It is important to 
note that even though only 27.7% of the participants in the current study achieved the 
weight loss goal, the majority (83.0%) of participants achieved the physical activity goal. 
There are many known and independent benefits of physical activity improving the 
complications related to prediabetes and diabetes. Independent of weight change, 
physical activity can improve insulin sensitivity and glucose metabolism; and reduce 
visceral adipose tissue concentrations, blood pressure, and cholesterol, to name a few 
(Cauza et al., 2005; Goodyear & Kahn, 1998; Kahn, 2003; Kraus et al., 2002). 
 One of the primary strengths of this study was the inclusion of physical activity 
measures. A significant increase in physical functioning was determined using the 6-
minute walk test. Mau et al. (2010) also found a significant increase in 6-minute walk 
distance in a DPP translation study for a Polynesian population. Additionally, we found 
significant improvements in self-reported measures using the RAPA. Though self-report 
data are known to be subject to participant bias, the improvements in the RAPA were 
supported by improvements in the 6-minute walk distance following the intervention 
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period. Furthermore, improvements in cardiovascular fitness are associated with 
reductions in the risk for T2D, cardiovascular disease, and all-cause mortality 
independent of weight loss (Eriksson & Lindgärde, 1991; Helmrich, Ragland, Leung, & 
Paffenbarger, 1991). 
 Another strength of the current study was the inclusion of an assessment of 
participant quality of life. It has been thought that those at risk for T2D may experience 
decreases in quality of life (Florez et al., 2012). This study found significant 
improvements in the total score related to quality of life in the QOLS following the 
lifestyle intervention, which is in line with improvements observed in the original DPP 
(Florez et al., 2012).  
 There were several limitations in this study. This sample of participants had low 
diversity, and was primarily female, which does not represent the broader population of 
individuals at risk for developing T2D. In fact, 15.5 million (13.6%) of those with T2D 
are male, while 13.4 million (11.2%) are female (CDC, 2015). Additionally, group 
meeting attrition over the course of the study and loss of participants to follow-up may 
have contributed to our difficulty in conducting group data analyses. Also, we did not 
assess any form of motivation in this study, and so we could not control for any self-
selection bias. 
 Future research should include measures of motivation, and whether it may be 
cost effective to provide one-on-one counseling with a wellness coach. Finally, future 
research in Utah should include greater diversity and additional male representation. Utah 
has the fifth highest population of Polynesians in the U.S. (Hixon, Hepler, & Kim, 2012), 
and when compared to the general population, Pacific Islanders have an 11% greater 
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prevalence of diabetes (Schiller, Lucas, Ward, & Peregoy, 2012). Thus, there is a need 
for targeted diabetes prevention research with the Polynesian population in Utah.  
 In conclusion, this pilot study demonstrated that the NDPP was effective at 
improving risk factors associated with prediabetes, in particular with reducing body 
weight and increasing physical activity in a sample of individuals from the University of 
Utah community. It is therefore suggested that the program be continued and that it be 
expand to the greater Salt Lake City region.  
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